We are live on ! Find out more
REPL icon

Replimune Group

53 hedge funds and large institutions have $287M invested in Replimune Group in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 12

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

1.2% more ownership

Funds ownership: 60.62%61.82% (+1.2%)

2% less capital invested

Capital invested by funds: $292M → $287M (-$5.64M)

2% less funds holding

Funds holding: 5453 (-1)

Holders
53
Holders Change
-1
Holders Change %
-1.85%
% of All Funds
1.15%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
4
Increased
19
Reduced
12
Closed
3
Calls
Puts
Net Calls
Net Calls Change

REPL Hedge Fund Activity: Q2 2019 in Review

53 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q2 2019, worth a combined $287M — down 1.9% from $292M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new REPL positions and 3 closed out — a net gain of 1 holder — while 19 added to existing stakes and 12 trimmed.

The largest buyer was BVF Inc, adding an estimated $1.7M. The largest seller was Fidelity Investments, cutting an estimated $671K.

  • 53 institutional investors held Replimune Group (REPL) as of Q2 2019, down from 54 in Q1 2019.
  • Funds reported $287M of Replimune Group stock for Q2 2019, down 1.9% quarter-over-quarter.
  • 4 funds opened new Replimune Group positions in Q2 2019 and 3 closed out, a net change of +1 holder.
  • The largest Replimune Group buyer in Q2 2019 was BVF Inc, an estimated $1.7M added.
  • The largest Replimune Group seller in Q2 2019 was Fidelity Investments, an estimated $671K sold.

Based on aggregated 13F filings for Q2 2019.